ページ内を移動するためのリンクです。

Financial Highlights

*From FY2016, International Financial Reporting Standards (IFRS) is applied.

Key Results (Tables)Click to view graphs.

Consolidated Financial Data (JPY billion / % change)

  FY2012 FY2013 FY2014※1
(Apr-Dec)
FY2015 FY2016
JGAAP IFRS IFRS
Net Sales 1,218.1 1,452.8 1,224.3 1,445.2 1,427.4 1,195.5
5.5% 19.3% -16.2%
Operating Profit 169.7 198.7 196.5 151.8 148.9 101.1
14.1% 17.1% -32.1%
Profit Attributable to Owners of Parent ※2 122.4 151.0 143.1 84.1 102.0 92.6
32.8% 23.3% -9.2%
Research and Development
Expenses
192.4 249.0 172.9 201.0 202.7 168.8
20.8% 29.4% -16.7%

Notes:

 1. Due to a change in the fiscal year end to December, FY2014, a transitional period for the change, covers nine months from April 1, 2014 to December 31, 2014.
Thus, percentage changes of FY2014 and FY2015 compared to the previous fiscal year are not applicable.

 2. Equivalent to Net Income under J-GAAP (Japanese Generally Accepted Accounting Principles).

  FY2012 FY2013 FY2014
(Apr-Dec)
FY2015 FY2016
JGAAP IFRS IFRS
Total Assets 1,779.2 2,028.4 2,178.2 2,528.5 2,575.3 2,478.3
Total Equity※3 1,325.1 1,510.8 1,658.6 1,683.4 1,727.4 1,738.4
Ratio of equity attributable to owners of parent to total assets※4 73.7 73.2 74.7 65.4 66.0 69.0

 3. Equivalent to Net Assets under J-GAAP.

 4. Equivalent to Shareholders' equity ratio under J-GAAP.

Geographical Segment Sales

  FY2016 (JPY billion) % of Net Sales
Japan 624.0 52.2
North America 309.2 25.9
Others 262.3 21.9
Total 1,195.5 100.0
Sales to customers by market.

Sales by Business Segment

  FY2016 (JPY billion) % of Net Sales
Pharmaceutical business 753.0 63.0
Nutraceutical business 300.9 25.2
Consumer products business 35.1 2.9
Other business 106.5 8.9
Total 1,195.5 100.0
Sales to customers by market.

Key Management Indicators

  FY2012 FY2013 FY2014
(Apr-Dec)
FY2015 FY2016
JGAAP IFRS IFRS
ROE (%) 9.7% 10.8% 9.2% 5.1% 6.1% 5.4%
EPS (yen) 221.9 278.1 264.2 155.1 188.2 170.8
Annual dividends per share (yen) 58.0 65.0 75.0 100.0 100.0 100.0
Payout ratio (%) 26.1% 23.4% 28.4% 64.5% 53.1% 58.5%

Key Results (Graphs)Click to view tables.

  • Graph:Net Sales

  • Graph:Operating Income

  • Graph:Research and Development Expenditure

  • Graph:Geographical Segment Sales

  • Sales by Business Segment